Sanofi's pediatric vaccine "Hexaxim" remains the most administered hexavalent vaccine in the world with 62% of volume share

NEW YORK, Nov. 23, 2020 /PRNewswire/ -- A new study on the usage patterns of pediatric hexavalent vaccines reveals that Sanofi's vaccine "Hexaxim" remains the most administered hexavalent vaccine in the world in 2019 with 62% of volume share, followed by Infanrix Hexa (32%,) and Vaxelis 6%.

Hexavalent vaccines are six in-one combination vaccines that protect babies against diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, haemophilus influenza type B and hepatitis B.

    --  In 2019, the top 35 countries consumed 22 million doses of hexavalent
        vaccines which represents 92% of the hexavalent vaccine global
        consumption. (Find the full list in the report)
    --  The top 35 countries are geographically diverse: Mexico (5.4 m doses),
        South Africa (3.5m million doses), followed by Germany,Vietnam, the UK,
        and France each consuming more than 2m doses.
    --  Overall, Europe accounts for 42% of the hexavalent vaccines market by
    --  In public markets (those where the Government bears part or all of the
        cost of immunisation), Hexaxim had an even higher share of 69%.
    --  Hexaxim is the only brand used in the national immunisation schedule in
        12 public markets: South Africa, Saudi Arabia, Mexico, Iraq, Libya,
        Chile, Panama, Kazakhstan, Belgium, Austria, Norway and Georgia.
    --  In 2019, 1.7 million doses of hexaxim were distributed for pre-term

Share of different hexavalent vaccine brands in top 35 countries Also, most public markets occur in high and upper middle-income countries and most private markets in lower middle- and low-income countries.

To read the summary and download the full report click here.
Feel free to contact me for more information or for an interview with the analysts in charge of this report.

Media Contact:
Intissar Guettou
T: +44 20 7193 1209

About Reportlinker Insight: Reportlinker Insight combines analysis and exclusive investigations. We cover innovations, social and economics megatrends to understand the world of tomorrow. For more information, please visit

View original content to download multimedia:

SOURCE Reportlinker